How Much Does Mounjaro Cost?

Mounjaro cost depends on your pharmacy, insurance and savings eligibility. Its list price is not a guaranteed out-of-pocket price, and Zepbound self-pay offers cannot be assumed to apply to Mounjaro.

Mounjaro and Zepbound have different programs

Mounjaro is indicated for type 2 diabetes; Zepbound has its own indications including weight management. Zepbound self-pay offers advertise a starting price of $299 for a four-week supply of 2.5 mg in a KwikPen or vials; this is a starting dose, not maintenance. Later costs depend on dose, device and refill terms. That offer does not establish a Mounjaro price. Check each manufacturer’s information, reviewed September 14, 2026. Source: Zepbound manufacturer savings terms Source: Mounjaro manufacturer cost information

What insurance changes

Coverage depends on the drug, diagnosis, plan formulary and prior authorization. Ask about the cost after your deductible and any required clinical documentation. Commercial savings and self-pay offers have different rules. Medicare GLP-1 Bridge is a temporary program for certain eligible beneficiaries beginning in July 2026; it does not mean automatic coverage for everyone. CMS: Medicare GLP-1 Bridge eligibility

REMEVi plans: billing period and total payment

REMEVi prices use four-week billing periods, which are not calendar months. The 12- and 24-week terms require the full total upfront. Lab work that the clinician requires for treatment is included.

Compounded preparation	Every 4 weeks	12 weeks: total upfront	24 weeks: total upfront
Injectable semaglutide	$199	$507 ($169/4 weeks)	$954 ($159/4 weeks)
Injectable tirzepatide	$269	$699 ($233/4 weeks)	$1,350 ($225/4 weeks)
Compounded oral semaglutide	$249	$687 ($229/4 weeks)	$1,290 ($215/4 weeks)

See current semaglutide and tirzepatide plan details. Compounded oral semaglutide is not an approved Wegovy, Ozempic or Rybelsus tablet. Eligibility and prescribing depend on clinical evaluation. Service is available in 49 states and Washington, DC, excluding Louisiana.

The product distinction matters

Compounded preparations are not FDA-approved, are not generics of the brands and do not have established clinical equivalence to them. FDA recommends their use only when an available approved product cannot meet the medical need. A lower price does not establish equal safety or effectiveness. Source: FDA: unapproved GLP-1 medicines

Before choosing

Confirm the product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy. Ask who handles side effects and what happens if clinical review does not recommend treatment. Review care options.